http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2008119276-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-33
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
filingDate 2006-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2009-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2008119276-A
titleOfInvention 3-ALKYL-5- (4-ALKYL-5-OXOTETRAHYDROFURAN-2-IL) PYRROLIDIN-2-ONE DERIVATIVES AS INTERMEDIATE COMPOUNDS IN THE SYNTHESIS OF RENIN INHIBITORS
abstract 1. The compound of formula (II)! ! where R3 is C1-C7 alkyl or C3-C8 cycloalkyl, and! R4 is C1-C7 alkyl, C2-C7 alkenyl, C3-C8 cycloalkyl, phenyl or naphthyl (C1-C4) alkyl, each unsubstituted or mono-, di- or trisubstituted by C1-C4 alkyl, O- (C1-C4) alkyl, OH , C1-C4 alkylamino, di (C1-C4 alkyl) amino, halogen and / or trifluoromethyl,! or its salt. ! 2. The compound according to claim 1, where R3 and R4 independently mean branched chain C3-C6 alkyl. ! 3. The compound according to claim 1 or 2, characterized by the following stereochemical structure:! ! 4. The compound according to claim 1 or 2 of the formula! ! 5. The compound of formula (II ')! ! where R3 is C1-C7 alkyl or C3-C8 cycloalkyl, and! R4 is C1-C7 alkyl, C3-C7 alkenyl, C3-C8 cycloalkyl, phenyl or naphthyl (C1-C4) alkyl, each unsubstituted or mono-, di- or trisubstituted by C1-C4 alkyl, O- (C1-C4) alkyl, OH , C1-C4 alkylamino, di (C1-C4 alkyl) amino, halogen and / or trifluoromethyl,! or its salt. ! 6. The compound of claim 5, wherein R3 and R4 are independently branched C3-C6 alkyl. ! 7. The compound according to claim 5 or 6, characterized by the following stereochemical structure:! ! 8. The compound according to claim 5 or 6 of the formula! ! 9. The method of obtaining the compounds of formula (II) according to any one of claims 1 to 4, which consists in the fact that the compound of formula (I ')! ! where R3 and R4 have the meanings indicated for the compound of formula (II), and Aux * means an auxiliary group capable of forming an ester or amide group in the carbonyl function, or its salt, is hydrogenated in the azide group to form the amino group and the lactam ring is closed. ! 10. The method of obtaining the compounds of formula (II) according to any one of claims 1 to 4, which consists in the fact that the compound of formula (I)! ! where R3 and R4 have the meanings indicated for the compound of formula (II), or a salt thereof, are hydrogenated at the azide group to form
priorityDate 2005-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419600705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455581532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465310064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71081
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454984946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411471813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164080528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467302241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163668743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466611031
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393625
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521561
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163488850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465053536
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588021
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466250073
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1117
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62406
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465909655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6326969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467400054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84468

Total number of triples: 64.